Positioning Community Pharmacies in Nigeria as a Clinical Trial Partner: A Forward Perspective
Decentralized clinical trials (DCTs) employ innovative approaches to conduct research outside traditional clinical sites. Low- and middle-income countries like Nigeria, with limited infrastructure, insufficient manpower, and inadequate financial support for trials, can benefit from DCTs. By leveraging non-traditional infrastructure, such as community pharmacies, DCT approaches could overcome some infrastructural and recruitment challenges common in clinical trials in African countries. The extensive community pharmacy network in Nigeria could be strategically positioned as partners in DCT efforts.
Authors
- Adeboye Olakunle Bamgboye (ORCID: https://orcid.org/0000-0003-2681-0899)
- Tobechı Brendan Nnanna (ORCID: https://orcid.org/0000-0001-9702-6124)
- Ibrahim Adebayo Hassan (ORCID: https://orcid.org/0000-0002-5995-6272)
- Babatunde M. Jinadu (ORCID: https://orcid.org/0009-0008-2215-6483)
- Luke A. Alade (ORCID: https://orcid.org/0009-0001-3081-5839)
Institutions
- University of Minnesota (US)
- Aston University (GB)
- Kleijnen Systematic Reviews (United Kingdom) (GB)
- Clinton Health Access Initiative (US)
- ACCESS Health International (US)
- Lagos State Health Service Commission (NG)
- Obafemi Awolowo University (NG)
Publication Details
- Journal
- Clinical and Translational Science
- Published
- 2026-04-01
- DOI
- https://doi.org/10.1111/cts.70548
- Primary Topic
- Pharmaceutical Quality and Counterfeiting
- Type
- article
- Field-Weighted Citation Impact
- 0.00